AMPH vs SPGI · P/E 12, rev $732.0M vs P/E 27, rev $15.34B
Amphastar P (AMPH) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the AMPH and SPGI stock pages for the full models.
Not investment advice.